Literature DB >> 23474821

Instruments for holistic assessment of Parkinson's disease.

Pablo Martinez-Martin1.   

Abstract

Assessment of Parkinson's disease is a complex matter as a consequence of the variety of manifestations and complications that can be present in a patient. Although a really holistic assessment is probably a utopia, a comprehensive evaluation is possible using a combination of measures completed by health professionals, patients and/or caregivers. In PD, main domains requiring assessment include motor impairment, motor complications, non-motor symptoms, disability, and patient-reported outcomes. Such scales like the Movement Disorder Society-Unified Parkinson's Disease Rating Scale and the battery of Scales for Outcomes in Parkinson's disease (SCOPA) provide a wide information on the most relevant aspects of the disease. Hoehn and Yahr staging, global impression, and quality of life measures furnish summarized whole evaluations and comprehensive non-motor symptom assessments help to identify and evaluate this kind of manifestations. This article shows a pragmatic review of common instruments (rating scales and questionnaires) usable for a comprehensive assessment of PD and provides information about sources for guiding the selection of measures and outcome analyses.

Entities:  

Mesh:

Year:  2013        PMID: 23474821     DOI: 10.1007/s00702-013-1005-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  31 in total

1.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

3.  Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.

Authors:  David A Gallagher; Christopher G Goetz; Glenn Stebbins; Andrew J Lees; Anette Schrag
Journal:  Mov Disord       Date:  2011-09-13       Impact factor: 10.338

4.  What outcomes matter to patients?

Authors:  C D Sherbourne; R Sturm; K B Wells
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Methods for interpreting change over time in patient-reported outcome measures.

Authors:  K W Wyrwich; J M Norquist; W R Lenderking; S Acaster
Journal:  Qual Life Res       Date:  2012-04-17       Impact factor: 4.147

7.  International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Authors:  P Martinez-Martin; C Rodriguez-Blazquez; K Abe; K B Bhattacharyya; B R Bloem; F J Carod-Artal; R Prakash; R A J Esselink; C Falup-Pecurariu; M Gallardo; P Mir; Y Naidu; A Nicoletti; K Sethi; Y Tsuboi; J J van Hilten; M Visser; M Zappia; K R Chaudhuri
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

Review 8.  Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.

Authors:  Marian L Evatt; K Ray Chaudhuri; Kelvin L Chou; Ester Cubo; Vanessa Hinson; Katie Kompoliti; Chengwu Yang; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

9.  A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.

Authors:  J Marinus; M Visser; A M Stiggelbout; J Martin Rabey; P Martínez-Martín; U Bonuccelli; P H Kraus; J J van Hilten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

10.  Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Mario Alvarez-Sanchez; Tomoko Arakaki; Alberto Bergareche-Yarza; Anabel Chade; Nelida Garretto; Oscar Gershanik; Monica M Kurtis; Juan Carlos Martinez-Castrillo; Amelia Mendoza-Rodriguez; Henry P Moore; Mayela Rodriguez-Violante; Carlos Singer; Barbara C Tilley; Jing Huang; Glenn T Stebbins; Christopher G Goetz
Journal:  J Neurol       Date:  2012-08-05       Impact factor: 4.849

View more
  5 in total

1.  Three-dimensional rodent motion analysis and neurodegenerative disorders.

Authors:  Tasos Karakostas; Simon Hsiang; Heather Boger; Lawrence Middaugh; Ann-Charlotte Granholm
Journal:  J Neurosci Methods       Date:  2013-10-12       Impact factor: 2.390

2.  Does spouse participation influence quality of life reporting in patients with Parkinson's disease?

Authors:  Chelsea D Morrow; Katherine Smentkowski; Stacy Schwartz; Melissa J Armstrong; Ann L Gruber-Baldini; Karen E Anderson; Stephen G Reich; William J Weiner; Lisa M Shulman
Journal:  Qual Life Res       Date:  2014-06-28       Impact factor: 4.147

3.  Turkish version of Parkinson Fatigue Scale: Validity and reliability study of binary scoring method.

Authors:  Erhan Arif Öztürk; Bilge Gönenli Koçer; Ebru Umay; Aytül Çakcı
Journal:  Turk J Phys Med Rehabil       Date:  2018-02-26

4.  Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.

Authors:  Panteleimon Oikonomou; Daniel J van Wamelen; Daniel Weintraub; Dag Aarsland; Dominic Ffytche; Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Valentina Leta; Corinne Borley; Carolina Sportelli; Dhaval Trivedi; Aleksandra M Podlewska; Katarina Rukavina; Alexandra Rizos; Claudia Lazcano-Ocampo; Kallol Ray Chaudhuri
Journal:  Brain Behav       Date:  2021-03-01       Impact factor: 2.708

5.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.